Contact us EN FR

Lysogene Announces first European patient treated in AAVance, Phase 2/3 Clinical Trial Investigating LYS-SAF302

Press Release

Latest tweet

Get in touch

Follow us

Join our mailing list

arrow-left arrow-right calendar contact download facebook linkedin location play reset rss twitter youtube